Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Compare brokers on costs, ease of use, and research tools to find the best fit for your index fund investing journey.
22,899 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
A recent internal survey found that nearly half of Harvard seniors acknowledge cheating at some point in college. The...
Want to protect cash flow while staying on the right side of the law? This guide shows real estate investors legally ...
U.S. stocks attempt to regain momentum on June 24, 2026, as investors digest fresh earnings and AI demand signals. Th...
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...
A Minneapolis-area father and son are under indictment for allegedly filing false tax refunds using a questionable se...
A 69-year-old widow faces a six-figure tax bill after considering rolling her late husband’s traditional IRA into her...
Bitcoin slipped below the $59,000 level for the first time in almost two years, intensifying a risk-off mood as Micro...
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
Strategy confronts a $12 billion unrealized loss on its bitcoin holdings as Bitcoin trades around $60,000, tightening...